Why shares in this ASX environmental company have soared 9% today

Here's a closer look at why the Phoslock Environmental Technologies Ltd (ASX: PET) share price is soaring today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Phoslock Environmental Technologies Ltd (ASX: PET) share price is up 9.5% at the time of writing following an update to the market earlier this morning on its operations in China, as well as the announcement of a new project in Brazil.

What does Phoslock do?

Phoslock is an international environmental company specialising in engineering solutions and water treatment products to remediate polluted lakes, rivers, canals and drinking water reservoirs. Phoslock has its headquarters in Sydney with offices in Brisbane, Beijing and Changxing, China, and Manchester, UK.

In 2017, Phoslock (Beijing) was formed to help remediate the massive Chinese algae and water pollution problem. Phoslock owns the patent for Phoslock, a water treatment product that inhibits the growth of harmful algal blooms (HAB) that lead to detrimental effects to both aquatic and human life. Phoslock (the product) is certified to be used in drinking water in North America, Europe, UK, Brazil, Australia and China.

The Phoslock share price has increased by over 100% during the past 12 months, peaking last August at a high of $1.52. It has since retreated, and has recently come under pressure due to coronavirus concerns. Phoslock shares are currently sitting at $0.81 with today's gains.

China update

Phoslock announced that its Beijing office is now back at work, with government approval to re-start its factory. It anticipates that production should ramp up over the next month. It noted that it has inventory held outside China to last until mid-year.

Phoslock has no treatments in China planned until late March to April and no delays are expected. It also notes there is no effect on FY2020 sales guidance.

Details of new Brazil project

Phoslock also announced that through its Brazilian licensee, Phoslock has received a contract from CEDEA to treat one of Rio de Janeiro city's main drinking reservoirs. The application has already commenced and will continue for the next 3 months, with an estimated value of over $2 million.

The company commented that this is a further instance of a growing number of local and government authorities in a range of countries having full confidence in using Phoslock in human drinking water reservoirs.

Phoslock further commented that Rio de Janeiro's high profile has generated substantial media coverage of this problem both in Brazil and internationally. Consequently, it believes that the application of Phoslock to this reservoir is likely to lead to similar applications elsewhere in Brazil and in other countries, as this particular problem is widespread.

Chair Laurence Freedman AM commented: "With each successful application of Phoslock in lakes, dams and reservoirs, our ability to dramatically transform heavily polluted waterbodies – even those suffering from eutrophication – adds to increasing global acceptance and demand for our services."

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

a woman with lots of shopping bags looks upwards towards the sky as if she is pondering something.
Opinions

The pros and cons of buying Zip shares in 2026

There are positive and negative aspects about Zip shares right now…

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Share Market News

Here's what Westpac says the RBA will do with interest rates in 2026

Stick or twist? Let's see what the RBA could do with rates this year.

Read more »

A woman stretches her arms into the sky as she rises above the crowd.
Best Shares

Fastest rising ASX 200 share of each market sector in 2025

These shares outperformed their sector peers last year.

Read more »

A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Aristocrat, James Hardie, and TechnologyOne shares

Morgans has given its verdict on these popular shares. Is it bullish, bearish, or something in between?

Read more »

Group of entrepreneurs feeling frustrated during a meeting in the office. Focus is on man with headache.
Share Fallers

5 worst ASX All Ords shares of 2025, and why brokers rate 4 of them a buy

The ASX All Ords rose by 7.11% in 2025 but as always, there were losers in the pack.

Read more »

A female soldier flies a drone using hand-held controls.
Best Shares

These 5 ASX All Ords shares were the fastest risers of 2025

The ASX All Ords rose by 7.11% and delivered total returns, including dividends, of 10.56% in 2025.

Read more »